Photo of Michael Bleicher

Michael Bleicher counsels and litigates privacy, data security, and First Amendment issues for clients in the technology and communications industries. He has in-depth knowledge of the Electronic Communications Privacy Act (ECPA), Stored Communications Act (SCA), state biometric privacy laws, and other federal and state privacy statutes.

Late last evening, the U.S. House of Representatives passed SAFE Banking legislation by voice vote, offered as an amendment to the National Defense Authorization Act (NDAA/H.R. 4350). While SAFE Banking legislation previously passed in the House, it had stalled in the Senate due to Republicans’ demands for changes that would have transformed the bill from one offering protection to financial institutions in the cannabis industry, to one enacting additional guardrails on federal marijuana policy. SAFE Banking legislation’s inclusion in a must-pass bill this time around marks a critical step in the effort to enact this legislation this Congress.

What is SAFE Banking legislation?

The SAFE Banking amendment would enable financial institutions to support the cannabis industry by eliminating two major risks of adverse government action. The proposed law explicitly permits financial institutions to do business with cannabis companies and prohibits the government from terminating or limiting a financial institution’s deposit or share insurance solely because the institution works with a cannabis business. These changes would remove current federal restrictions that have resulted in only a limited number of financial institutions currently willing to take on the risk of banking cannabis companies. And those that do charge exorbitant fees and costs that foreclose the services to many—predominately impacting small and diversity-owned entities. As a result, the economic development of all cannabis industries, and especially small and diversity-owned entities, has been impeded through reduced liquidity, heightened entry barriers, and heightened security issues for some businesses forced to depend upon cash transactions.
Continue Reading U.S. House Votes SAFE Banking Legislation into Defense Bill

While most people are discussing federal legalization of cannabis these days, the industry operates at a local level and the role of state-level cannabis associations is crucial. Perkins Coie associate Michael Bleicher is joined by Truman Bradley, Executive Director of the Marijuana Industry Group (MIG), the oldest and largest trade association in Colorado for the legal cannabis industry. During the podcast, Michael and Truman discuss how cannabis regulation currently varies all the way down to the city level and whether a one-size-fits-all approach to federal legalization would be effective or if a more nuanced approach is needed. Truman also shares his thoughts on how the pandemic has impacted the cannabis industry in Colorado.
Continue Reading The Role of State-Level Cannabis Associations: A Conversation with Truman Bradley

As cannabis is legalized on a state-by-state basis, individual states are creating their own cannabis testing requirements to ensure consumer safety, and many of these requirements differ from one state to the next.  Perkins Coie associate Michael Bleicher is joined by Alena Rodriguez, Managing Director of Rm3 Labs, a leading cannabis testing laboratory in Colorado.

Today, the U.S. Federal Trade Commission (FTC) announced a settlement in its most recent law enforcement action in its ongoing efforts to monitor the marketplace regarding misleading cannabidiol (CBD) product claims. The action targets Kushly Industries LLC (Kushly) and the company’s sole officer for allegedly making false or unsupported health benefit claims about Kushly’s CBD product.
Continue Reading FTC Continues Crackdown on Unsupported CBD Marketing

Most Americans are familiar with the term “THC” at this point. What they might not yet appreciate is that common nomenclature is actually referring to Delta-9-tetrahydrocannabinol or “Delta-9” THC. That’s the scientific terminology for the molecule in marijuana that’s well-known for its psychoactive properties—i.e., what causes a “high.” Delta-9 is a cannabinoid and there are hundreds of different cannabinoids within any given cannabis plant.
Continue Reading Delta-8: A New Low in Highs

Perkins Coie is proud to announce the launch of “Cannabis Law: A Primer on Federal and State Law Regarding Marijuana, Hemp, and CBD,” published by the American Bar Association, authored by various Perkins Coie Cannabis Law attorneys, and edited by Barak Cohen, chair of our Cannabis Law industry group, and Michael Bleicher. Until

Two recent actions from the Biden Administration may have immediate consequences for the cannabis industry. First, a new Executive Order signed by President Biden reversed prior policy requiring federal agencies to submit guidance documents to the White House for review. Second, the Biden Administration distributed a memorandum to federal agencies asking them to postpone any rules published in the Federal Register for 60 days.
Continue Reading Looking Ahead: Cannabis Policy Update January 2021

In our latest podcast, Perkins Coie associate Michael Bleicher is joined by Dr. Tim Shu, founder and CEO of VetCBD, a startup marketing CBD-infused supplements for pets. Tim and Michael discuss the rewards and challenges of launching a business amid the current patchwork of cannabis laws, the scientific context for VetCBD’s products, and policy changes

The U.S. Department of Agriculture (USDA) published a final rule today, building off the interim final rule it issued in October 2019 and incorporating both public comments and the agency’s takeaways from the 2020 growing season. In general, the final rule makes modest adjustments to the interim final rule in order to make it less onerous for producers to grow hemp while imposing stricter requirements on how crop must be tested.

Most importantly, the final rule recognizes that growers may accidentally produce crop that contains more than 0.3 percent THC and raises the limit for negligently doing so from 0.5 percent to 1 percent, but requires that producers test for total THC levels in crop, rather than for delta-9 THC levels. Testing for total THC levels makes it more likely a crop could exceed the legal limit for THC in hemp.
Continue Reading USDA’s Final Rule Makes Hemp Easier to Grow, Harder to Test